BioSpace News Archive

Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today updated a key clinical development milestone and reported its second-quarter 2021 financial results.

Kintara Therapeutics, Inc announced today that its Chief Executive Officer, Saiid Zarrabian , will present at the Investor Summit Conference being held August 17 – 18, 2021.

Lynk Pharmaceuticals Co., Ltd. , announced today that it has administered its triple-kinase inhibitor LNK01002 to the first patient in a phase I clinical trial.

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of an investigational therapy Haduvio™ to treat serious neurologically mediated conditions, announced financial results for the quarter ended June 30, 2021, as well as business updates.

AbCellera, a technology company with a centralized operating system for next-generation antibody discovery, announced financial results for the second quarter of 2021.

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, reported its financial results for the quarter ended June 30, 2021 and provided a business update.

VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today reported financial results for its fiscal year 2022 first quarter ended June 30, 2021 and provided a corporate update.

Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today reported financial results for the second quarter of 2021.

Today, the American Diabetes Association® and 14 other leading voluntary health organizations and medical societies concerned with diabetes urged the Centers for Disease Control and Prevention (CDC) to consider the health risks people with diabetes are facing with COVID-19 as the agency develops guidance on special patient populations who may benefit from additional COVID-19 vaccine doses

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET.